BHC(SH:600721) Sou Hu Cai Jing·2025-11-08 19:02Core Points - Baihua Pharmaceutical (600721) closed at 8.96 yuan on November 7, 2025, down 0.33% from 8.99 yuan the previous week [1] - The company's total market capitalization is 3.446 billion yuan, ranking 45th out of 50 in the medical services sector and 4303rd out of 5166 in the A-share market [1] Company Announcements - Baihua Pharmaceutical plans to use surplus reserves of 5,030,274.41 yuan and capital reserves of 1,905,507,702.14 yuan to offset accumulated losses [1] - As of December 31, 2024, the parent company's accumulated undistributed profits stand at -1,910,537,976.55 yuan, with surplus reserves of 5,030,274.41 yuan and capital reserves of 2,260,280,858.86 yuan [1] - The total amount to be used for loss offsetting is 1,910,537,976.55 yuan, which will bring undistributed profits to zero [1] - The plan aims to improve the financial situation, enable profit distribution, and enhance investor return capabilities [1] - This proposal has been submitted for review at the second extraordinary general meeting of shareholders in 2025 [1]